Advertisement
Screener

VolitionRx Limited (VNRX) Proceeds from Short-term Capital Lease Obligations

2.6 / 5 stars · 32/62 Roast Me

VolitionRx Limited Proceeds from Short-term Capital Lease Obligations

VolitionRx Limited (VNRX) reported Proceeds from Short-term Capital Lease Obligations of -$97.42 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-22.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromShortTermCapitalLeaseObligations · last filed 2021-03-22

  • VolitionRx Limited proceeds from short-term capital lease obligations for fiscal 2020 was -$97.42K.
  • VolitionRx Limited proceeds from short-term capital lease obligations for fiscal 2019 was -$142.04K.
Period endProceeds from Short-term Capital Lease Obligations 6 monthProceeds from Short-term Capital Lease Obligations 12 month
2020-12-31-$97.42K
10-K · filed 2021-03-22
2019-12-31-$142.04K
10-K · filed 2021-03-22
2019-06-30-$71.17K
10-Q · filed 2019-08-12
2018-06-30-$72.52K
10-Q · filed 2019-08-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
BIOMERICA INC (BMRA)United States$0.011B
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92